Design of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) Trial

Mineralocorticoid receptor (MR) activation plays an essential role in promoting inflammation, fibrosis, and target organ damage. Currently, no studies are investigating MR antagonism in patients with type 2 diabetes mellitus (T2DM) with chronic kidney disease, at high risk for cardiovascular complic...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Cardiol
Main Authors: Rajagopalan, Sanjay, Alaiti, M. Amer, Broadwater, Kylene, Goud, Aditya, Gaztanaga, Juan, Connelly, Kim, Fares, Anas, Shirazian, Shayan, Kreatsoulas, Catherine, Farkouh, Michael, Dobre, Mirela, Fink, Jeffrey C., Weir, Matthew R.
格式: Artigo
語言:Inglês
出版: Wiley Periodicals, Inc. 2017
主題:
Trial Designs
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490527/
https://ncbi.nlm.nih.gov/pubmed/28555959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22718
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍